Lista de obras - Joaquim Ferreira - Dominio Público Uruguay

(Dys)Prosody in Parkinson's Disease: Effects of Medication and Disease Duration on Intonation and Prosodic Phrasing

artículo científico publicado en 2021

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

scientific article published in The Lancet

A genome-wide association study in multiple system atrophy

artículo científico publicado en 2016

A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease

artículo científico publicado en 2011

A randomized, rater‐blinded, parallel trial of intensive speech therapy in sub‐acute post‐stroke aphasia: the SP‐I‐R‐IT study ⬇️

artículo científico publicado el 16 de abril de 2013

Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?

scientific article published on 15 June 2018

An evidence-based approach in the treatment of Huntington's disease.

artículo científico

Associated movement disorders in orthostatic tremor.

artículo científico publicado en 2012

Association of Body Mass Index and Parkinson Disease

artículo científico publicado en 2024

Automatic Detection of Parkinson’s Disease: An Experimental Analysis of Common Speech Production Tasks Used for Diagnosis

scholarly article by Anna Pompili et al published 2017 in Lecture Notes in Computer Science

Branded versus generic clopidogrel in cardiovascular diseases: a systematic review.

artículo científico publicado en 2013

Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies.

artículo científico publicado en 2013

Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family

artículo científico publicado en 2002

Co-designing Customizable Clinical Dashboards with Multidisciplinary Teams: Bridging the Gap in Chronic Disease Care

artículo científico publicado en 2024

Comments on: 'Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'.

artículo científico publicado en 2018

Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: Identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants ⬇️

artículo científico publicado el 28 de mayo de 2013

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

artículo científico publicado en 2006

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

artículo científico publicado en 2011

Cross-cultural adaptation and validation of the Swallowing Disturbance Questionnaire and the Sialorrhea Clinical Scale in Portuguese patients with Parkinson's disease

scientific article published on 10 August 2020

Current and future therapeutic strategies for Parkinson's disease.

artículo científico publicado en 2009

DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

artículo científico publicado en 1997

Dopamine agonist therapy in early Parkinson's disease

artículo científico publicado en 2008

Dysarthria in individuals with Parkinson's disease: a protocol for a binational, cross-sectional, case-controlled study in French and European Portuguese (FraLusoPark).

artículo científico publicado en 2016

Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease

artículo científico publicado en 2018

Eslicarbazepine acetate: a new option for the treatment of focal epilepsy

artículo científico publicado en 2009

Espresso Coffee for the Treatment of Somnolence in Parkinson's Disease: Results of n-of-1 Trials

artículo científico publicado en 2016

Feasibility of using risk prompts to prevent falls, dehydration and pulmonary aspiration in nursing homes: a clinical study protocol

artículo científico publicado en 2018

GIGYF2 mutations are not a frequent cause of familial Parkinson's disease

artículo científico publicado en 2009

Has “levodopa-induced neuropathy” been reported in Parkinson's disease clinical trials?

artículo científico publicado en 2011

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

article published in 2010

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

artículo científico publicado en 2008

Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials

artículo científico publicado en 2012

Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson's disease

artículo científico publicado en 2020

Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?

artículo científico publicado en 2019

Late-stage Parkinson disease.

artículo científico

Levodopa response in later stages of Parkinson's disease: A case-control study

scientific article published on 29 October 2019

Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review

artículo científico publicado en 2019

Morphine in acute coronary syndrome: systematic review and meta-analysis

artículo científico publicado en 2019

N-Terminal Pro-B-Type Natriuretic Peptide Levels in Parkinson's Disease

artículo científico publicado en 2020

Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial

artículo científico

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

artículo científico publicado en 2015

Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA.

artículo científico publicado en 2017

Parkinson disease: adjunctive entacapone therapy increases risk of dyskinesia.

artículo científico publicado en 2010

Pharmacotherapy in Parkinson's disease: case studies.

artículo científico publicado en 2010

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

artículo científico publicado en 2008

Physician perception versus true efficacy of tetrabenazine for Huntington’s disease

artículo científico publicado en 2018

Piribedil for levodopa-induced complications in Parkinson's disease

artículo científico publicado en 2007

Piribedil for symptomatic management of Parkinson's disease

artículo científico publicado en 2007

Piribedil versus levodopa in early Parkinson's disease

artículo científico publicado en 2007

Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.

artículo científico publicado en 2000

Psychosocial impact of Parkinson's disease-associated dysarthria: Cross-cultural adaptation and validation of the Dysarthria Impact Profile into European Portuguese

artículo científico publicado en 2018

Putaminal petechial haemorrhage as the cause of non-ketotic hyperglycaemic chorea: a neuropathological case correlated with MRI findings.

artículo científico publicado en 2007

Quality and reporting of guidelines on the diagnosis and management of dystonia

artículo científico publicado en 2017

Rasagiline for levodopa-induced motor complications in Parkinson´s disease

artículo científico publicado en 2007

Recovery after copper-deficiency myeloneuropathy in Wilson’s disease

artículo científico publicado en 2013

Referral to rehabilitation in Parkinson's disease: who, when and to what end?

artículo científico publicado en 2013

Reply to letter: Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis

scientific article published on 29 November 2019

Reply to the letter 'We never speak about sudden unexpected death in Parkinson's disease'

scientific article published on 16 March 2020

Scales to assess sleep impairment in Parkinson's disease: critique and recommendations

scientific article published on December 2010

Should the Energy Contribution of Commercial Thickeners Be Considered in the Nutrition Plan of Patients With Dysphagia?

artículo científico publicado en 2019

Skin cancer and Parkinson's disease

scientific article published on January 2010

Skin cancers and precancerous lesions in Parkinson's disease patients.

artículo científico publicado en 2007

Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.

artículo científico publicado en 2006

Sneeze as a precipitating factor of cerebral venous thrombosis

artículo científico publicado en 2007

Speech intelligibility of Parkinson's disease patients evaluated by different groups of healthcare professionals and naïve listeners

artículo científico publicado en 2020

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

artículo científico

Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study

artículo científico publicado en 2018

Temporal stability of the Unified Dyskinesia Rating Scale

artículo científico publicado en 2011

The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series

scientific article published on 10 December 2019

The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis

artículo científico publicado en 2020

The launch of opicapone for Parkinson's disease: negatives versus positives

artículo científico publicado en 2018

The management of patients with early Parkinson's disease.

artículo científico publicado en 2002

Therapeutic interventions for daytime somnolence in Parkinson's disease

artículo científico publicado en 2007

Therapeutic interventions for disease progression in Huntington's disease

artículo científico publicado en 2009

Therapeutic interventions for disease progression in Huntington's disease

artículo científico publicado en 2007

Therapeutic interventions for sleep disorders in Parkinson's disease

artículo científico publicado en 2007

Therapeutic interventions for symptomatic treatment in Huntington's disease

artículo científico publicado en 2009

Therapeutic interventions for symptomatic treatment in Huntington's disease

artículo científico publicado en 2007

Treatment options for non-motor symptoms in late-stage Parkinson's disease

artículo científico publicado en 2008

Upper limb tremor induced by peripheral nerve injury.

artículo científico publicado en 2006

Usefulness of OSLER test in Parkinson's disease

artículo científico publicado en 2012

Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.

artículo científico publicado en 2013

What motivates Parkinson’s disease patients to enter clinical trials? ⬇️

artículo científico publicado el 28 de junio de 2011

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.

artículo científico publicado en 2009

Lista de obras de Joaquim Ferreira

(Dys)Prosody in Parkinson's Disease: Effects of Medication and Disease Duration on Intonation and Prosodic Phrasing

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

A genome-wide association study in multiple system atrophy

A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease

A randomized, rater‐blinded, parallel trial of intensive speech therapy in sub‐acute post‐stroke aphasia: the SP‐I‐R‐IT study ⬇️

Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?

An evidence-based approach in the treatment of Huntington's disease.

Associated movement disorders in orthostatic tremor.

Association of Body Mass Index and Parkinson Disease

Automatic Detection of Parkinson’s Disease: An Experimental Analysis of Common Speech Production Tasks Used for Diagnosis

Branded versus generic clopidogrel in cardiovascular diseases: a systematic review.

Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies.

Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family

Co-designing Customizable Clinical Dashboards with Multidisciplinary Teams: Bridging the Gap in Chronic Disease Care

Comments on: 'Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'.

Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: Identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants ⬇️

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

Cross-cultural adaptation and validation of the Swallowing Disturbance Questionnaire and the Sialorrhea Clinical Scale in Portuguese patients with Parkinson's disease

Current and future therapeutic strategies for Parkinson's disease.

DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

Dopamine agonist therapy in early Parkinson's disease

Dysarthria in individuals with Parkinson's disease: a protocol for a binational, cross-sectional, case-controlled study in French and European Portuguese (FraLusoPark).

Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease

Eslicarbazepine acetate: a new option for the treatment of focal epilepsy

Espresso Coffee for the Treatment of Somnolence in Parkinson's Disease: Results of n-of-1 Trials

Feasibility of using risk prompts to prevent falls, dehydration and pulmonary aspiration in nursing homes: a clinical study protocol

GIGYF2 mutations are not a frequent cause of familial Parkinson's disease

Has “levodopa-induced neuropathy” been reported in Parkinson's disease clinical trials?

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials

Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson's disease

Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?

Late-stage Parkinson disease.

Levodopa response in later stages of Parkinson's disease: A case-control study

Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review

Morphine in acute coronary syndrome: systematic review and meta-analysis

N-Terminal Pro-B-Type Natriuretic Peptide Levels in Parkinson's Disease

Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA.

Parkinson disease: adjunctive entacapone therapy increases risk of dyskinesia.

Pharmacotherapy in Parkinson's disease: case studies.

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Physician perception versus true efficacy of tetrabenazine for Huntington’s disease

Piribedil for levodopa-induced complications in Parkinson's disease

Piribedil for symptomatic management of Parkinson's disease

Piribedil versus levodopa in early Parkinson's disease

Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.

Psychosocial impact of Parkinson's disease-associated dysarthria: Cross-cultural adaptation and validation of the Dysarthria Impact Profile into European Portuguese

Putaminal petechial haemorrhage as the cause of non-ketotic hyperglycaemic chorea: a neuropathological case correlated with MRI findings.

Quality and reporting of guidelines on the diagnosis and management of dystonia

Rasagiline for levodopa-induced motor complications in Parkinson´s disease

Recovery after copper-deficiency myeloneuropathy in Wilson’s disease

Referral to rehabilitation in Parkinson's disease: who, when and to what end?

Reply to letter: Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis

Reply to the letter 'We never speak about sudden unexpected death in Parkinson's disease'

Scales to assess sleep impairment in Parkinson's disease: critique and recommendations

Should the Energy Contribution of Commercial Thickeners Be Considered in the Nutrition Plan of Patients With Dysphagia?

Skin cancer and Parkinson's disease

Skin cancers and precancerous lesions in Parkinson's disease patients.

Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.

Sneeze as a precipitating factor of cerebral venous thrombosis

Speech intelligibility of Parkinson's disease patients evaluated by different groups of healthcare professionals and naïve listeners

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study

Temporal stability of the Unified Dyskinesia Rating Scale

The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series

The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis

The launch of opicapone for Parkinson's disease: negatives versus positives

The management of patients with early Parkinson's disease.

Therapeutic interventions for daytime somnolence in Parkinson's disease

Therapeutic interventions for disease progression in Huntington's disease

Therapeutic interventions for disease progression in Huntington's disease

Therapeutic interventions for sleep disorders in Parkinson's disease

Therapeutic interventions for symptomatic treatment in Huntington's disease

Therapeutic interventions for symptomatic treatment in Huntington's disease

Treatment options for non-motor symptoms in late-stage Parkinson's disease